Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Plasma cell disorders

Did a bot eat your homework? An assessment of the potential impact of bad actors in online administration of preference surveys

Juan Marcos Gonzalez, Kiran Grover, Thomas W. Leblanc, Bryce B. Reeve

Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea

Ka-Won Kang, Min Ji Jeon, [ ... ], Hwa Jung Sung

Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study

Nora Hafez, Lobna Refaat, [ ... ], Lamiaa A. Fathalla

Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan

Shuji Uno, Shuichi Midorikawa, [ ... ], Kenshi Suzuki

Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study

Anita Marx, Magdolna Osváth, [ ... ], Imre Kacskovics

RWD-derived response in multiple myeloma

Tao Xu, James Roose, [ ... ], Stefka Tyanova

Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders

Hila Magen, Abraham Avigdor, [ ... ], Galia Rahav

Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database

Hiroshi Handa, Tadao Ishida, [ ... ], Shinsuke Iida

Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices

Miyuki Takasu, Ryo Higashino, [ ... ], Kazuo Awai

Calprotectin as new potential clinical marker for multiple myeloma

Parisa Khosravi, Saeid Abroun, [ ... ], Homayoun Sarough Farahani

Evaluating the screening value of serum light chain ratio, β₂ microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves

Limei Ying, Xiaochang Zhang, [ ... ], Linglong Xu

Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer

Chandru Gajendran, Subramanyam Janardhan Tantry, [ ... ], Dhanalakshmi Sivanandhan

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

Mailee Huynh, Hae Yeun Chang, [ ... ], Shigeki Miyamoto

Advertisement

Create a weekly email alert for: Plasma cell disorders

You can change these options by clicking profile then "Alerts and Notifications"